CORCEPT THERAPEUTICS INC Other Comprehensive Income (Loss), Net of Tax
CORCEPT THERAPEUTICS INC (CORT) reported Other Comprehensive Income (Loss), Net of Tax of -$1.35 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-04-30
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$1.35M, a 248.07% decline year-over-year.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was $909.00K.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax for fiscal 2025 was $2.48M.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax for fiscal 2024 was -$826.00K, a 155.89% decline from fiscal 2023.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax for fiscal 2023 was $1.48M.
- CORCEPT THERAPEUTICS INC other comprehensive income (loss), net of tax for fiscal 2022 was -$642.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|
| 2026-03-31 | -$1.35M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $2.48M 10-K · filed 2026-02-24 | |
| 2025-03-31 | $909.00K 10-Q · filed 2026-04-30 | |
| 2024-12-31 | -$826.00K 10-K · filed 2026-02-24 | |
| 2023-12-31 | $1.48M 10-K · filed 2026-02-24 | |
| 2022-12-31 | -$642.00K 10-K · filed 2025-02-26 | |
| 2021-12-31 | -$642.00K 10-K · filed 2024-02-15 | |
| 2020-12-31 | $154.00K 10-K · filed 2023-02-28 | |
| 2019-12-31 | $331.00K 10-K · filed 2022-02-15 | |
| 2018-12-31 | $5.00K 10-K · filed 2021-02-23 | |
| 2017-12-31 | -$75.00K 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |